GLCT Sposnoring the "2015 State of Edgewater" Event

Great Lakes Clinical Trials is proud to be a sponsor and at this year's State of Edgewater event. Confirmed speakers include 40th Ward Alderman Patrick O’Connor, 48th Ward Alderman Harry Osterman, Board President Toni Preckwinkle, Rep. Greg Harris, and Senator Heather Steans.

Elected representatives will discuss how their work impacts Edgewater, from the ward level to federal level, and everything in between.  Great Lakes Clinical Trials president, Steve Satek will be a co-presenter at the event.

 

GLCT's Pain Specialist, Dr. Kiran Chekka, Helps Nepalese Earthqualke Relief Effort

Our Great Lakes Clinical Trials pain specialist, Dr. Kiran Chekka, has been volunteering his medical time in Nepal for a number of years, through Operation Walk Chicago.  The mission of Operation Walk Chicago is to improve the quality of life of disadvantaged patients around the world through reducing disability from advanced joint disease.

The recent devastating earthquake in Nepal's Kathmandu Valley has hit close to home for us at Great Lakes. Our team is highly supportive of the fundraising efforts of Operation Walk Chicago. Please consider a donation to help the Nepalese through this important group by clicking on this link. Any contribution is greatly appreciated.

Thanks.

Dr. Chekka with Operation Walk Chicago in Katmandu, Nepal

Dr. Chekka with Operation Walk Chicago in Katmandu, Nepal

Great Lakes Clincial Trials to Attend 15th International Congress on Schizophrenia Research

Steve Satek, Great Lakes Clinical Trials Co-Founder and President, will be attending the 15th International Congress on Schizophrenia Research from March 28- April 1, 2015 in Colorado Springs, CO

This is a biennial meeting where scientists representing the broad range of disciplines involved with discovery in schizophrenia gather to exchange data, techniques, and ideas. Many scientists are current contributors to the scientific literature.

"This is a chronic disease that is not only devastating to those affected and their family, but to society as a whole," commented Mr. Satek. "Great Lakes Clinical Trials is proud to be committed to high-quality, compassionate schizophrenia research through our many community mental health partners in the Chicagoland area."

GLCT Sposnors Alderman Harry Osterman’s 15th Annual Senior Health Fair

Great Lakes' Clinical Trials Team Members, Maura Stefanik, Megon Holldorf and Dean Hervochon

Great Lakes' Clinical Trials Team Members, Maura Stefanik, Megon Holldorf and Dean Hervochon

A big thank you goes out to all the Chicagoland seniors who attended the Alderman Harry Osterman’s 15th Annual Senior Health Fair on March 16, 2015.  Hundreds of Chicagoland residents visited our booth at the Broadway Armory, learned about our various clinic trials and signed up for free memory screens.

Great Lakes also provided a fun "Brain Age" computer game where participants who completed the one-minute test, were able to get a comparison of how "old" their brain is compared to thousands of others who have previously taken the test. Over 50 residents participated in the game.

"We are proud to offer a valuable service to our local seniors," commented Steve Satek, Great Lakes Clinical Trials' President. "We offer seniors the opportunity to participate in clinical trials, free-of-charge, where they can do their part to help get new medications approved for themselves and future generations."

GLCT Welcomes Pain Specialist Kiran Chekka, MD To Our Research Team

Kiran Chekka, MD

In the spirit of Great Lakes Clinical Trials’ commitment to quality neuroscience research, we are proud to announce that Kiran Chekka, MD has joined our team to head up our Pain Research program. 

Kiran Chekka, MD, is a Fellowship Trained Interventional Pain Physician and Double Board Certified Anesthesiologist. Dr. Chekka was accepted into the prestigious Pennsylvania State University-Thomas Jefferson University accelerated medical program directly from high school. After completing his medical education at Jefferson Medical College, he completed Anesthesia residency training at Northwestern University and then completed a pain medicine fellowship at Northwestern during which he served as Chief Fellow.

Dr. Chekka then served as an Assistant Professor at Northwestern University for four years. During this period, Dr. Chekka published original research and abstract publications in Acute Pain Medicine, Regional Anesthesia, and Chronic Pain Medicine.  Dr. Chekka presented original research for four straight years at the prestigious American Society of Regional Anesthesia and the American Society of Anesthesiology annual meetings.

As one of the first graduates of a multi-disciplinary pain fellowship, Dr. Chekka truly believes in a compassionate team approach to treating chronic pain. He focuses on functional restoration and improvement of quality of life as well as reduction of pain.

In addition to his research activities, Dr. Chekka maintains one of the largest pain management practices in the State of Illinois, with five partners across seven locations, Premier Pain Specialists.

Matinas BioPharma Appoints Great Lakes Clinical Trials Investigator, Dr. Kevin Maki to Their Scientific Advisory Board

Dr. Kevin Maki, GLCT Investigator

Dr. Kevin Maki, GLCT Investigator

Matinas BioPharma Holding, Inc., an emerging biopharmaceutical company focused on the development and commercialization of omega-3 fatty acid-based prescription therapeutics for the treatment of cardiovascular and metabolic conditions, announced today that it has appointed Kevin C. Maki, Ph.D. to its recently formed Scientific Advisory Board.

Dr. Maki is a leading clinical lipid specialist with extensive experience in the design and conduct of clinical trials in human nutrition, metabolism and chronic disease management. He has participated in more than 250 clinical trials and observational studies as an investigator, consultant or statistician. Dr. Maki is the Founder and Chief Science Officer of the Midwest Center for Metabolic & Cardiovascular Research, serves as a Clinical Investigator at Great Lakes Clinical Trials and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University in Chicago. He is a certified Clinical Lipid Specialist and a Fellow of the National Lipid Association, The Obesity Society and the American College of Nutrition, as well as a member of the Board of Governors of the Accreditation Council for Clinical Lipidology. Dr. Maki is also a member and spokesperson for the National Lipid Association's Expert Panel, and a co-author on the paper setting forth the NLA's patient-centered recommendations for dyslipidemia management.

Click here for a link to the full press release.